For research use only. Not for therapeutic Use.
UR-<wbr></wbr>144 (Item No. <span class=/itemid/>11502</span>) is a potent synthetic cannabinoid (CB) which preferentially binds the peripheral CB<sub>2</sub> receptor (K<sub>i</sub> = 1.8 nM) over the central CB<sub>1</sub> receptor (K<sub>i</sub> = 150 nM). (±)-<wbr></wbr>UR-<wbr></wbr>144 N-<wbr></wbr>(4-<wbr></wbr>hydroxypentyl) metabolite is an expected phase I metabolite of UR-<wbr></wbr>144, based on the metabolism of similar cannabimimetics. It is possible that this metabolite may be detectable in either serum or urine. The physiological and toxicological properties of this compound have not been tested. This product is intended for forensic and research applications.
| Catalog Number | R059492 |
| CAS Number | 1537889-04-5 |
| Synonyms | (1-(4-Hydroxypentyl)-1H-indol-3-yl)(2,2,3,3-tetramethylcyclopropyl)methanone; |
| Molecular Formula | C21H29NO2 |
| Purity | ≥95% |
| Storage | -20°C |
| IUPAC Name | [1-(4-hydroxypentyl)indol-3-yl]-(2,2,3,3-tetramethylcyclopropyl)methanone |
| InChI | InChI=1S/C21H29NO2/c1-14(23)9-8-12-22-13-16(15-10-6-7-11-17(15)22)18(24)19-20(2,3)21(19,4)5/h6-7,10-11,13-14,19,23H,8-9,12H2,1-5H3 |
| InChIKey | YHFHYHZNLCEAAP-UHFFFAOYSA-N |
| SMILES | CC(CCCN1C=C(C2=CC=CC=C21)C(=O)C3C(C3(C)C)(C)C)O |
